IDXX Today - Aug 07: Clinical Visits Keep Falling
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
So, what went down? The stock barely moved, but hey, a green day is still a win, right? It closed at $594.14. The vibe was pretty chill, with volume right on par with what we usually see. Nothing crazy happened, but it’s always nice when a stock doesn’t get smoked.
Now, onto the juicy bits. You might have heard that clinical visits are still on the decline, which sounds pretty rough. IDEXX’s Q2 earnings report mentioned that this drop in visits doesn’t really matter for them right now. Apparently, they’ve raised their earnings outlook for 2026, which is a big deal. You know how it goes—if the numbers are looking good, investors tend to be less worried about the short-term bumps.
But here’s the kicker: Zoetis, a major player in the pet healthcare world, just slashed their annual forecasts due to slowing demand. You’d think that would send shockwaves through the sector, but nope! Zoetis’ stock actually climbed today. It’s wild how the market reacts, right? IDEXX seems to be riding that wave of optimism despite the headwinds.
One quick thing worth knowing? IDEXX is banking on their strong earnings outlook to keep investors happy, even as the clinical visits trend downward. It’s a bit of a balancing act, but they seem confident.
So, to wrap it up, IDEXX had a decent day despite some challenges in the pet healthcare space. It’s always a mixed bag in this market, but they’re holding their own. Remember, this is just a recap for info and entertainment, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません